Latest Michael D. Lockshin Stories
NEW YORK, March 18, 2011 /PRNewswire/ -- Motivated by the lack of treatment options for patients with antiphospholipid syndrome (APS), rheumatology researchers convened an international committee to address the problem directly.
EXTON, Pa., Dec. 21, 2010 /PRNewswire/ -- BioTrends Research Group, Inc. is pleased to announce the publication of a new syndicated report focused on the management and treatment of systemic lupus erythematosus (SLE) in the U.S.
NEW YORK, Dec.
Hospital for Special Surgery physicians who focus on lupus, scleroderma and related conditions are traveling from New York City to Atlanta this week to share their recent findings at the 74th Annual Scientific Meeting of the American College of Rheumatology (ACR).
NEW YORK, July 2 /PRNewswire/ -- Hospital for Special Surgery (HSS) plans to host a two-day international Osteoarthritis Summit in June 2011.
The effects of Systemic Lupus Erythematosus (SLE) may differ based on the individual patient's genealogical heritage.
The Chinese Systemic Lupus Erythematosus (SLE) Treatment and Research Group (CSTAR) announced interim epidemiological information on SLE patients in China today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy.
NEW YORK, Feb.
Largest US study to date finds mortality outcomes improving.
NEW YORK, Jan, 13 /PRNewswire/ -- Hospital for Special Surgery today announced that Mary K. Crow, M.D. has been appointed Physician-In-Chief and Chair of the Division of Rheumatology. This appointment is effective as of April 1. Dr.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.